Dagmar Schlenzig

1.7k total citations
27 papers, 1.4k citations indexed

About

Dagmar Schlenzig is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dagmar Schlenzig has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dagmar Schlenzig's work include Peptidase Inhibition and Analysis (11 papers), Alzheimer's disease research and treatments (8 papers) and Neuropeptides and Animal Physiology (7 papers). Dagmar Schlenzig is often cited by papers focused on Peptidase Inhibition and Analysis (11 papers), Alzheimer's disease research and treatments (8 papers) and Neuropeptides and Animal Physiology (7 papers). Dagmar Schlenzig collaborates with scholars based in Germany, Canada and United States. Dagmar Schlenzig's co-authors include Hans‐Ulrich Demuth, Hans‐Ulrich Demuth, Raymond A. Pederson, Christopher H.S. McIntosh, Robert P. Pauly, Stephan Schilling, Susanne Manhart, Martin Kleinschmidt, Jens‐Ulrich Rahfeld and Gerd Hause and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Medicine.

In The Last Decade

Dagmar Schlenzig

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dagmar Schlenzig Germany 15 644 495 490 403 370 27 1.4k
Susanne Manhart Canada 18 793 1.2× 530 1.1× 519 1.1× 474 1.2× 279 0.8× 26 1.5k
Tomiichiro Oda Japan 20 868 1.3× 320 0.6× 689 1.4× 59 0.1× 300 0.8× 31 1.5k
M. Zarándi Hungary 16 386 0.6× 255 0.5× 421 0.9× 290 0.7× 149 0.4× 25 1.1k
Chahrzad Montrose‐Rafizadeh United States 28 1.3k 2.1× 648 1.3× 208 0.4× 872 2.2× 215 0.6× 53 2.5k
Anja Rosengarth United States 13 912 1.4× 365 0.7× 273 0.6× 225 0.6× 90 0.2× 15 1.7k
Natalia V. Koudinova Russia 18 544 0.8× 205 0.4× 519 1.1× 113 0.3× 96 0.3× 28 1.3k
Jonathan C. Cruz United States 17 1.1k 1.7× 394 0.8× 744 1.5× 46 0.1× 304 0.8× 18 2.0k
Alfredo Giménez-Cassina Spain 21 979 1.5× 314 0.6× 382 0.8× 59 0.1× 108 0.3× 29 1.5k
Vicki Olm United States 8 704 1.1× 395 0.8× 1.2k 2.4× 53 0.1× 145 0.4× 8 1.7k
Bianca Plouffe Canada 19 1.1k 1.7× 587 1.2× 111 0.2× 225 0.6× 78 0.2× 34 1.5k

Countries citing papers authored by Dagmar Schlenzig

Since Specialization
Citations

This map shows the geographic impact of Dagmar Schlenzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Schlenzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Schlenzig more than expected).

Fields of papers citing papers by Dagmar Schlenzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Schlenzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Schlenzig. The network helps show where Dagmar Schlenzig may publish in the future.

Co-authorship network of co-authors of Dagmar Schlenzig

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Schlenzig. A scholar is included among the top collaborators of Dagmar Schlenzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Schlenzig. Dagmar Schlenzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jäger, Christian, et al.. (2023). Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2165648–2165648. 3 indexed citations
2.
Bayly-Jones, Charles, Hariprasad Venugopal, Michael Wermann, et al.. (2022). Helical ultrastructure of the metalloprotease meprin α in complex with a small molecule inhibitor. Nature Communications. 13(1). 6178–6178. 8 indexed citations
3.
Jäger, Christian, Dagmar Schlenzig, Michael Wermann, et al.. (2021). Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor. International Journal of Molecular Sciences. 22(11). 5651–5651. 9 indexed citations
4.
Jäger, Christian, et al.. (2020). Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach. ChemMedChem. 16(6). 976–988. 11 indexed citations
5.
Wermann, Michael, et al.. (2018). Continuous assays for meprin alpha and beta using prolyl tripeptidyl aminopeptidase (PtP) from Porphyromonas gingivalis. Analytical Biochemistry. 559. 11–16. 7 indexed citations
6.
Jäger, Christian, et al.. (2018). Tertiary‐Amine‐Based Inhibitors of the Astacin Protease Meprin α. ChemMedChem. 13(16). 1619–1624. 9 indexed citations
7.
Richter, Georg, Dagmar Schlenzig, Stefanie Geißler, et al.. (2018). Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors. Journal of Medicinal Chemistry. 61(10). 4578–4592. 13 indexed citations
8.
Schlenzig, Dagmar, Holger Cynis, Maike Hartlage‐Rübsamen, et al.. (2018). Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation. Journal of Alzheimer s Disease. 66(1). 359–375. 19 indexed citations
9.
Schlenzig, Dagmar, et al.. (2017). Concerted action of dipeptidyl peptidase IV and glutaminyl cyclase results in formation of pyroglutamate-modified amyloid peptides in vitro. Neurochemistry International. 113. 112–119. 21 indexed citations
10.
Schlenzig, Dagmar & Stephan Schilling. (2017). Heterologous Expression of the Astacin Protease Meprin β in Pichia pastoris. Methods in molecular biology. 1579. 35–45. 3 indexed citations
11.
Schlenzig, Dagmar, et al.. (2017). First insight into structure-activity relationships of selective meprin β inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(11). 2428–2431. 16 indexed citations
12.
Wulff, Melanie, Jay Kant Yadav, Uwe Knüpfer, et al.. (2016). Enhanced Fibril Fragmentation of N‐Terminally Truncated and Pyroglutamyl‐Modified Aβ Peptides. Angewandte Chemie International Edition. 55(16). 5081–5084. 36 indexed citations
13.
Schlenzig, Dagmar, et al.. (2015). Expression, purification and initial characterization of human meprin β from Pichia pastoris. Protein Expression and Purification. 116. 75–81. 11 indexed citations
14.
Schlenzig, Dagmar, Raik Rönicke, Holger Cynis, et al.. (2012). N‐Terminal pyroglutamate formation of Aβ38 and Aβ40 enforces oligomer formation and potency to disrupt hippocampal long‐term potentiation. Journal of Neurochemistry. 121(5). 774–784. 74 indexed citations
15.
Brandt, Wolfgang, Andrea Porzel, Dagmar Schlenzig, et al.. (2010). Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus. Bioorganic & Medicinal Chemistry. 18(6). 2173–2177. 34 indexed citations
16.
Schlenzig, Dagmar, Susanne Manhart, Martin Kleinschmidt, et al.. (2009). Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides. Biochemistry. 48(29). 7072–7078. 165 indexed citations
17.
Schilling, Stephan, Ulrike Zeitschel, Torsten Hoffmann, et al.. (2008). Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology. Nature Medicine. 14(10). 1106–1111. 288 indexed citations
18.
Niestroj, André J., Dagmar Schlenzig, Ulrich Heiser, et al.. (2005). Acylated Hydroxamates as Selective and Highly Potent Inhibitors of Dipeptidyl Peptidase I. Kluwer Academic Publishers eBooks. 524. 339–343. 2 indexed citations
19.
Pospisilik, J. Andrew, Simon A. Hinke, Raymond A. Pederson, et al.. (2001). Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regulatory Peptides. 96(3). 133–141. 60 indexed citations
20.
Demuth, Hans‐Ulrich, et al.. (1993). Design of (ω‐N‐(O‐acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline‐specific peptidases. FEBS Letters. 320(1). 23–27. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Manhart Breakdown of academic impact, for papers by Tomiichiro Oda Breakdown of academic impact, for papers by M. Zarándi Breakdown of academic impact, for papers by Chahrzad Montrose‐Rafizadeh Breakdown of academic impact, for papers by Anja Rosengarth Breakdown of academic impact, for papers by Natalia V. Koudinova Breakdown of academic impact, for papers by Jonathan C. Cruz Breakdown of academic impact, for papers by Alfredo Giménez-Cassina Breakdown of academic impact, for papers by Vicki Olm Breakdown of academic impact, for papers by Bianca Plouffe
Rankless by CCL
2026